These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2296990)
21. Re: a new name for the holistic SIG. Faragher T Aust Vet J; 2012 Oct; 90(10):N22. PubMed ID: 23173233 [No Abstract] [Full Text] [Related]
22. [Our experience in teaching pharmacology to foreign students]. Zolotukhin SI Farmakol Toksikol; 1979; 42(5):557-9. PubMed ID: 488335 [No Abstract] [Full Text] [Related]
23. Re: what's in a name by isaacs d 2009 and children's nomenclatural adventurism and medical evaluation study by Willis F R et Al. 2009. Trivedi A J Paediatr Child Health; 2011 Jan; 47(1-2):68. PubMed ID: 21255152 [No Abstract] [Full Text] [Related]
28. [Generic name or brand name?]. Madsen S Tidsskr Nor Laegeforen; 2006 Feb; 126(4):431. PubMed ID: 16477277 [No Abstract] [Full Text] [Related]
29. [Pharmacology general concepts]. Carrillo Norte JA Rev Enferm; 2010 Jan; 33(1):44-6. PubMed ID: 20201199 [TBL] [Abstract][Full Text] [Related]
30. [Classification of current epidemiological terminology in categories and specific rules. II. Rules of epidemiology]. Ionescu T; Ivan IM Microbiol Parazitol Epidemiol (Bucur); 1969; 14(6):481-6. PubMed ID: 5378444 [No Abstract] [Full Text] [Related]
31. [Present classification of the terminology of epidemiology in specific categories and laws. I. Epidemiologic categories]. Ivan IM; Ionescu T Microbiol Parazitol Epidemiol (Bucur); 1969; 14(5):423-9. PubMed ID: 4903910 [No Abstract] [Full Text] [Related]
32. THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. THE NEED FOR A QUANTITATIVE APPROACH TO THE STUDY OF "DEPRESSANT TRANQUILIZERS". BEECHER HK; SMITH GM J Neuropsychiatr; 1964 Oct; 5():465-71. PubMed ID: 14249420 [No Abstract] [Full Text] [Related]
33. Letter: To name or not to name names. Haslam KR Med Instrum; 1973; 7(1):21. PubMed ID: 4784331 [No Abstract] [Full Text] [Related]
35. [Pharmacotherapeutic equivalence in drugs]. van der Meer J Ned Tijdschr Geneeskd; 1973 Mar; 117(13):525-6. PubMed ID: 4695162 [No Abstract] [Full Text] [Related]
37. Trade names or approved names. Point II. Points of view. The clinical pharmacologist. Turner P Postgrad Med J; 1974 Feb; 50(580):93-5. PubMed ID: 4465784 [TBL] [Abstract][Full Text] [Related]
38. The limitations of molecular pharmacology. Hall TC J Clin Pharmacol New Drugs; 1971; 11(5):322. PubMed ID: 4105286 [No Abstract] [Full Text] [Related]
39. A comparison of two approaches to the construction of models for quantal responses to mixtures of drugs. Plackett RL; Hewlett PS Biometrics; 1967 Mar; 23(1):27-44. PubMed ID: 6050470 [No Abstract] [Full Text] [Related]
40. [No one is disgraced by the name. About the drug manufacturers' choice of name of their products]. Spigset O Tidsskr Nor Laegeforen; 1995 Jan; 115(3):380-3. PubMed ID: 7855842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]